Stockscreener 앱 받기
16.28
0.73%
-0.12
시간 외 거래:
16.25
-0.03
-0.18%
전일 마감가:
$16.40
열려 있는:
$16.25
하루 거래량:
110.02K
Relative Volume:
0.87
시가총액:
$481.87M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.05%
1개월 성능:
-6.60%
6개월 성능:
+15.63%
1년 성능:
+25.33%
1일 변동 폭
$16.08
$16.32
1주일 범위
$16.08
$16.82
52주 변동 폭
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Compare HQL vs DNP, UTG, ADX, UTF, KYN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.28 | 485.42M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.19 | 3.89B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
40.18 | 3.72B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.37 | 2.76B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
25.62 | 2.54B | 0 | 0 | 0 | 0.00 |
|
KYN
Kayne Anderson Energy Infrastructure Fund Inc
|
14.08 | 2.35B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors 주식(HQL)의 최신 뉴스
Aug Wrap: Can Classover Holdings Inc. deliver alphaGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Earnings Report: Is Abrdn Life Sciences Investors benefiting from innovation trends2026 Support & Resistance & Verified Short-Term Plans - baoquankhu1.vn
Income Plays: Will Abrdn Life Sciences Investors stock recover after earningsMarket Trend Summary & Reliable Trade Execution Plans - baoquankhu1.vn
Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Decreases By 37.6% - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Drop in Short Interest - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Stock Price Up 2.5%Still a Buy? - MarketBeat
Will Abrdn Life Sciences Investors stock deliver long term returnsJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Naître et grandir
Sentiment Recap: Can Abrdn Healthcare Investors reach all time highs this year2025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 (2026-03-06) - Seeking Alpha
First Trust entities jointly hold 3.02M shares of abrdn Life Sciences Investors (HQL) - Stock Titan
THQTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses - mx.advfn.com
HQL PE Ratio & Valuation, Is HQL Overvalued - Intellectia AI
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - mx.advfn.com
Layoff Watch: Will Abrdn Life Sciences Investors stock hit new highs in YEARDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 361.3% in February - Defense World
Sectors Review: Will Abrdn Life Sciences Investors stock hit new highs in YEAR2025 Growth vs Value & Comprehensive Market Scan Insights - baoquankhu1.vn
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
Abrdn World Healthcare Fund Q4 2025 Commentary (THW) - Seeking Alpha
Abrdn Life Sciences Investors Fund Q4 2025 Commentary (HQL) - Seeking Alpha
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Aug Swings: Should I hold or sell Abrdn Healthcare Investors nowRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary - Seeking Alpha
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm (2026-02-23) - Seeking Alpha
What is Abrdn Life Sciences Investors s 5 year growth outlookWeekly Trend Report & Technical Pattern Based Signals - mfd.ru
Will Abrdn Life Sciences Investors benefit from rising consumer demandJuly 2025 Update & Verified Entry Point Signals - mfd.ru
Abrdn Healthcare Investors Fund Q4 2025 Commentary - Seeking Alpha
Aug Macro: Can THCH reach all time highs this yearQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-19) - Seeking Alpha
Abrdn Life Sciences Investors To Go Ex-Dividend On February 20th, 2026 With 0.56 USD Dividend Per Share - 富途牛牛
abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month HighTime to Buy? - MarketBeat
Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com Australia
Will Abrdn Life Sciences Investors stock recover after earningsTake Profit & Fast Moving Stock Watchlists - mfd.ru
Market Catalysts: How volatile is Abrdn Life Sciences Investors stockJuly 2025 Review & Fast Entry Momentum Alerts - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Decline in Short Interest - MarketBeat
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately (2026-02-14) - Seeking Alpha
Why Abrdn Life Sciences Investors stock is favored by top institutionsEarnings Beat & Community Shared Stock Ideas - mfd.ru
MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-14) - Seeking Alpha
Is Abrdn Healthcare Investors forming a double bottom2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Will Abrdn Healthcare Investors stock deliver long term returnsQuarterly Profit Review & Breakout Confirmation Trade Signals - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Should I add Abrdn Life Sciences Investors stock to my portfolio2025 Top Gainers & Weekly Breakout Watchlists - mfd.ru
Will Abrdn Healthcare Investors stock hit new highs in YEARStock Surge & Free Fast Entry Momentum Trade Alerts - mfd.ru
Should value investors consider Abrdn Healthcare InvestorsTrade Exit Report & Verified Momentum Stock Alerts - mfd.ru
What’s the outlook for Abrdn Life Sciences Investors’s sectorJuly 2025 Momentum & Stepwise Trade Signal Guides - mfd.ru
abrdn Healthcare Investors (NYSE:HQH) Sets New 52-Week HighShould You Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.56 Per Share - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) to Issue Dividend Increase$0.63 Per Share - MarketBeat
VIX Spike: What’s the outlook for Abrdn Life Sciences Investors’s sectorTreasury Yields & Verified Swing Trading Watchlists - mfd.ru
abrdn Healthcare Investors (HQH) Declares $0.63 Dividend - GuruFocus
Technical Analysis: Is ANTX stock a value trapJuly 2025 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Abrdn Life Sciences Investors (HQL) 재무 분석
Abrdn Life Sciences Investors (HQL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.72%
0.27%
자본화:
|
볼륨(24시간):